European Neuropsychopharmacology

European Neuropsychopharmacology

欧洲神经精神药理学

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《European Neuropsychopharmacology》是由Elsevier出版社于1990年创办的英文国际期刊(ISSN: 0924-977X,E-ISSN: 1873-7862),该期刊长期致力于临床神经病学领域的创新研究,主要研究方向为医学-精神病学。作为SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA未开放获取模式(OA占比0.2170...%),以发表临床神经病学领域等方向的原创性研究为核心(研究类文章占比73.49%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在83篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

European Neuropsychopharmacology审稿周期约为 偏慢,4-8周 。该刊近年未被列入国际预警名单,年发文量约83篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 83 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
CLINICAL NEUROLOGY 临床神经病学 NEUROSCIENCES 神经科学 PHARMACOLOGY & PHARMACY 药学 PSYCHIATRY 精神病学
2区 2区 2区 2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
CLINICAL NEUROLOGY 临床神经病学 NEUROSCIENCES 神经科学 PHARMACOLOGY & PHARMACY 药学 PSYCHIATRY 精神病学
2区 2区 2区 2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:CLINICAL NEUROLOGY SCIE Q1 22 / 277

92.2%

学科:NEUROSCIENCES SCIE Q1 33 / 310

89.5%

学科:PHARMACOLOGY & PHARMACY SCIE Q1 26 / 354

92.8%

学科:PSYCHIATRY SCIE Q1 21 / 276

92.6%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CLINICAL NEUROLOGY SCIE Q1 49 / 278

82.55%

学科:NEUROSCIENCES SCIE Q1 61 / 310

80.48%

学科:PHARMACOLOGY & PHARMACY SCIE Q1 46 / 354

87.15%

学科:PSYCHIATRY SCIE Q1 45 / 276

83.88%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:10.3 SJR:1.756 SNIP:1.221
学科类别 分区 排名 百分位
大类:Medicine 小类:Pharmacology (medical) Q1 17 / 272

93%

大类:Medicine 小类:Psychiatry and Mental Health Q1 47 / 567

91%

大类:Medicine 小类:Neurology Q1 18 / 192

90%

大类:Medicine 小类:Neurology (clinical) Q1 37 / 400

90%

大类:Medicine 小类:Pharmacology Q1 33 / 313

89%

大类:Medicine 小类:Biological Psychiatry Q1 8 / 51

85%

期刊发文

  • Effect of psychotropics on the risk of COVID-19 in middle-aged and older adults

    Author: Ma, Yue; Li, Shu; Yang, Hongxi; Zhang, Yuan; Li, Huiping; Xu, Fusheng; Hou, Yabing; Zhang, Xinyu; Wang, Yaogang

    Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2023; Vol. 66, Issue , pp. 67-77. DOI: 10.1016/j.euroneuro.2022.11.009

  • Association between the loudness dependence of auditory evoked potential, serotonergic neurotransmission and treatment outcome in patients with depression

    Author: Ip, Cheng-Teng; Ganz, Melanie; Ozenne, Brice; Olbrich, Sebastian; Beliveau, Vincent; Dam, Vibeke H.; Kohler-Forsberg, Kristin; Jorgensen, Martin B.; Frokjaer, Vibe G.; Knudsen, Gitte M.

    Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2023; Vol. 70, Issue , pp. 32-44. DOI: 10.1016/j.euroneuro.2023.02.008

  • Inflammatory disequilibrium and lateral ventricular enlargement in treatment-resistant schizophrenia

    Author: Chen, Wenjin; Gou, Mengzhuang; Wang, Leilei; Li, Na; Li, Wei; Tong, Jinghui; Zhou, Yanfang; Xie, Ting; Yu, Ting; Feng, Wei; Li, Yanli; Chen, Song; Tian, Baopeng; Tan, Shuping; Wang, Zhiren; Pan, Shujuan; Luo, Xingguang; Zhang, Ping; Huang, Junchao; Tian, Li; Li, Chiang -Shan R.; Tan, Yunlong

    Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2023; Vol. 72, Issue , pp. 18-29. DOI: 10.1016/j.euroneuro.2023.03.014

  • Functional asymmetry of thalamocortical networks in subjects at ultra-high risk for psychosis and first-episode schizophrenia

    Author: Furong Zhu, Yi Liu, Feng Liu, Ru Yang, Huabing Li, Jindong Chen, David N. Kennedy, Jingping Zhao, Wenbin Guo

    Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, Vol., , DOI:10.1016/j.euroneuro.2019.02.006

  • Altered striatal reward processing in abstinent dependent cannabis users: Social context matters

    Author: Kaeli Zimmermann, Keith M. Kendrick, Dirk Scheele, Wolfgang Dau, Markus Banger, Wolfgang Maier, Bernd Weber, Yina Ma, René Hurlemann, Benjamin Becker

    Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, Vol., , DOI:10.1016/j.euroneuro.2019.01.106

  • Combined fluvoxamine and extended-release methylphenidate improved treatment response compared to fluvoxamine alone in patients with treatment-refractory obsessive-compulsive disorder: A randomized double-blind, placebo-controlled study

    Author: Huirong Zheng, Fujun Jia, Hongying Han, Shibin Wang, Guangquan Guo, Dongming Quan, Gang Li, Huiyan Huang

    Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2018, Vol., , DOI:10.1016/j.euroneuro.2018.12.010

  • Role of adipokines FGF21, leptin and adiponectin in self-concept of youths with obesity

    Author: Ge Li, Dan Feng, Xiaoxue Qu, Junling Fu, Yonghui Wang, Lianxia Li, Lujiao Li, Lanwen Han, Issy C. Esangbedo, Mingyao Li, Ming Li, Shan Gao

    Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2018, Vol., , DOI:10.1016/j.euroneuro.2018.05.015

  • Baseline serum vascular endothelial growth factor levels predict treatment response to antipsychotic medication in patients with schizophrenia

    Author: Wenhuan Xiao, Qiongqiong Zhan, Fei Ye, Xiaowei Tang, Jin Li, Hui Dong, Weiwei Sha, Xiaobin Zhang

    Journal: EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2018, Vol.28, 603-609, DOI:10.1016/j.euroneuro.2018.03.007